Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma

New England Journal of Medicine

Volumn 334, Issue 23, 1996, Pages 1505-1511

  Ambros, Ingeborg M ^a,b   Zellner, Andrea ^a   Roald, Borghild ^c   Amann, Gabriele ^b   Ladenstein, Ruth ^a   Printz, Dieter ^a   Gadner, Helmut ^a   Ambros, Peter F ^a,d  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CHILD; CHROMOSOME 1P; CHROMOSOME DELETION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; ONCOGENE C MYB; PLOIDY; PRIORITY JOURNAL; SCHOOL CHILD; SCHWANN CELL;

CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; GANGLIA; HUMANS; IN SITU HYBRIDIZATION; INFANT; MALE; NEUROBLASTOMA; PLOIDIES; SCHWANN CELLS;

EID: 0029977194     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199606063342304     Document Type: Article

References (53)

1. D'Angio GJ, Evans AE, Koop CE. Special pattern of widespread neuroblastoma with a favourable prognosis. Lancet 1971;1:1046-9.
2. Evans AE, Chatten J, D'Angio GJ, Gerson JM, Robinson J, Schnaufer L. A review of 17 IV-S neuroblastoma patients at the Children's Hospital of Philadelphia. Cancer 1980;45:833-9.
3. Haas D, Ablin AR, Miller C, Zoger S, Matthay KK. Complete pathologic maturation and regression of stage IV-S neuroblastoma without treatment. Cancer 1988;62:818-25.
4. Matthay KK, Sathet HN, Seeger RC, Haase GM, Hammond GD. Excellent outcome of stage II neuroblastoma is independent of residual disease and radiatíon therapy. J Clin Oncol 1989;7:236-44.
5. Kushner BH, Cheung N-KV, LaQuaíia MP, et al. Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. J Clin Oncol 1996;14:373-81.
6. Bessǹo F, Hashizume K, Nakajo T, Kamoshita S. Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children. J Pediatr 1991;119:237-41.
7. Brodeur GM, Green Green AA, Hayes FA. Williams KJ, Williams DL, Tsiatis AA. Cytogenetic features of human neurblastomas and cell lines. Cancer Res 1981;41:4678-86.
8. Gilbert F, Balaban G, Moornead P, Bianchi D, Schlesinger H. Abnormalities of chromosome 1p in human neuroblasroma tumors and cell lines. Cancer Genet Cytogenet 1982;7:33-42.
9. Kaneko Y, Kanda N, Maseki N, et al. Different karyotypic patterns in early and advanced stage neuroblastoma. Cancer Res 1987;47:311-8.
10. Hayashi Y, Kanda N, Inaba T, et al. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome I. Cancer 1989;63:126-32.
11. Brodeur GM, Nakagwara A. Molecular basis of clinical heterogeneity in neuroblastoma. Am J Pediatr Hematol Oncol 1992;14:111-6.
12. Ambros PF, Ambros IM, Strehl S, et al. Regression and progression in neuroblastoma: does genetics predict tumour behaviour? Eur J Cancer 1995; 31A:510-5.
13. Caron H, van Sluis P, de Kraker J, et al. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med 1996;334:225-30.
14. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984;224:1121-4.
15. Seeger RC, Brodeur GM; Sather H, et al. Association of multiple copies of the N-myc oncogene wìth rapid progression of neuroblastomas. N Engl J Med 1985;313:1111-6.
16. Fong CT, Dracopoli NC, White PS, et al, Loss of heterozygosity for the short arm of chromosome I in;.hurhan: neuroblastoma: correlation with N-Myc amplification Proc Natl Acad Sci U S A 1989;86:3753-7.
17. Look AT, Hayes FA, Shuster JJ, et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 1991;9:581-91.
18. Shimada H, Chatten J, Newton WA Jr, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984; 73:405-16.
19. Sidell N, Sarafian T, Kelly M, Tsuchida T, Haussler M. Retinoic acid-induced differentiation of human neuroblastoma: a cell variant system showing two distinct responses. Exp Cell Biol 1986;54:287-300.
20. Tsokos M, Scarpa S, Ross RA, Triche TJ. Differentiation of human neuroblastoma recapitulates neural crest development: study of morphology, neurotransmitter enzymes, and extracellular matrix proteins. Am J Pathol 1987:128:484-96.
21. Hopman AHN, van Hooren E, van de Kaa CA, Vooijs PG, Ramaekers FCS. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers. Mod Pathol 1991;4:503-13.
22. Stock C, Ambros IM, Mann G, Gadner H, Amann G, Ambros PF. Detection of 1p36 deletions in paraffin sections of neuroblastoma tissue. Genes Chromosom Cancer 1993;6:1-9.
23. Evans AE, D'Angio GJ, Randolph J. A proposed staging for children with neuroblastoma. Cancer 1971;27:374-8.
24. Cooke HJ, Hindley J. Cloning of human satellite III DNA: different components are on different chromosomes. Nucleic Acids Res 1979;6:3177-97.
25. Jabs EW, Wolf SF, Migeon BR. Characterization of a cloned DNA sequence that is present at centromeres of all human autosomes and the X chromosome and shows polymorphic variation. Proc Natl Acad Sci U S A 1984; 81:4884-8.
26. Devilee P, Kievits T, Waye JS, Pearson PL, Willard HF. Chromosome-specific alpha satellite DNA: isolation and mapping of a polymorphic alphoid repeat from human chromosome 10. Genomics 1988:3:1-7.
27. Looijenga LHJ, Smit VTHBM, Wessels JW, et al. Localization and polymorphism of a chromosome 12-specific α satellite DNA sequence. Cytogenet Cell Genet 1990;53:216-8.
28. Waye JS, Willard HF. Structure, organization, and sequence of alpha satellite DNA from human chromosome 17: evidence for evolution by unequal crossing-over and an ancestral pentamer repeat shared with the human X chromosome. Mol Cell Biol 1986;6:3156-65.
29. Giannakudis J, Vortkamp A, Kabisch R, Schmitt-Lingner E, Grzeschik KH. A hypervariable region located near 1pter. Cytogenet Cell Genet 1987;46: 619-20. abstract.
30. Buroker N, Bestwick R, Haight G, Magenis RE, Litt M. A hypervariable repeated sequence on human chromosome 1p36. Hum Genet 1987;77:175-81.
31. Strehl S, Ambros PF. Fluorescence in situ hybridization combined with immunohistochemistry for highly sensitive detection of chromosome 1 aberrations in neuroblastoma. Cytogenet Cell Genet 1993;63:24-8.
32. Van Roy N, Laureys G, Versteeg R, Opdenakker G, Speleman F. High-resolution fluorescence mapping of 46 DNA markers to the short arm of human chromosome 1. Genomics 1993;18:71-8.
33. Heiden T, Wang N, Tribukait B. An improved Hedley method for preparation of paraffin-embedded tissues for flow cytometric analysis of ploidy and S-phase. Cytometry 1991:12:614-21.
34. Taylor SR, Blatt J, Costantino JP, Roederer M, Murphy RF. Flow cytometric DNA analysis of neuroblastoma and ganglioneuroma: a 10-year retrospective study. Cancer 1988:62:749-54.
35. Mitelman F, ed. Catalog of chromosome aberrations in cancer. 5th ed. New York: Wiley-Liss, 1994.
36. Stock C, Ambros IM, Lion T, et al. Detection of numerical and structural chromosome abnormalities in pediatric germ cell tumors by means of interphase cytogenetics. Genes Chromosom Cancer 1994; 11:40-50.
37. Wood PM, Bunge RP. Evidence that sensory axons are mitogenic for Schwann cells. Nature 1975;256:662-4.
38. Salzer JL, Bunge RP. Studies of Schwann cell proliferation. I. An analysis in tissue culture of proliferation during development, Wallerian degeneration, and direct injury. J Cell Biol 1980:84:739-52.
39. Idem. Studies of Schwann cell proliferation. II. Characterization of the stimulation and specificity of the response to a neurite membrane fraction. J Cell Biol 1980:84:753-66.
40. Salzer JL, Bunge RP, Glaser L. Studies of Schwann cell proliferation. III. Evidence for the surface localization of the neurite mitogen. J Cell Biol 1980:84:767-78.
41. Ratner N, Hong DM, Lieberman MA, Bunge RP, Glaser L. The neuronal cell-surface molecule mitogenic for Schwann cells is a heparin-binding protein. Proc Natl Acad Sci U S A 1988;85:6992-6.
42. Nordlund M, Hong D, Fei X, Ratner N. Schwann cells and cells in the oligodendrocyte lineage proliferate in response to a 50,000 dalton membrane-associated mitogen present in developing brain. Glia 1992:5:182-92.
43. Bressler JP, Grotendorst GR, Levitov C, Hjelmeland LM. Chemotaxis of rat brain astrocytes to platelet derived growth factor. Brain Res 1985;344:249-54.
44. Weinmaster G, Lemke G. Cell-specific cyclic AMP-mediated induction of the PDGF receptor. EMBO J 1990;9:915-20.
45. Davis JB, Stroobant P. Platelet-derived growth factors and fibroblast growth factors are mitogens for rat Schwann cells. J Cell Biol 1990; 110:1353-60.
46. Lemke GE, Brockes JP. Identification and purification of glial growth factor, J Neurosci 1984:4:75-83.
47. Ridley AJ, Davis JB, Stroobant P. Land H. Transforming growth factorsbeta 1 and 2 are mitogens for rat Schwann cells. J Cell Biol 1989:109:3419-24.
48. Johnson EM Jr, Taniuchi M, DiStefano PS. Expression and possible function of nerve growth factor receptors on Schwann cells. Trends Neurosci 1988:11:299-304.
49. Lim R, Miller JF, Zaheer A. Purification and characterization of glia maturation factor β: a growth regulator for neurons and glia. Proc Natl Acad Sci U S A 1989;86:3901-5.
50. Lim R, Liu YX, Zaheer A. Glia maturation factor β regulates the growth of N18 neuroblasloma cells. Dev Biol 1990;137:444-50.
51. Reynolds ML, Woolf CJ. Reciprocal Schwann cell-axon interactions. Curr Opin Neurobiol 1993:3:683-93.
52. Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur GM. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Cancer Res 1992:52:1364-8.
53. Kogner P, Barbany G, Dominici C, Castello MA, Raschella G, Persson H. Coexpression of messenger RNA for trk protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res 1993:53:2044-50.